Prolific Machines is ushering in a new era of biotechnology with light. We harness light to produce everyday essentials more efficiently, from food and lifesaving drugs to novel biosolutions. Our first-of-its-kind photomolecular biology platform delivers unprecedented control, precisely guiding cellular behavior when and where it matters most. Unlike existing tools used to control biology, our technology unlocks dynamic control over virtually any cellular function in any cell type. We are enabling partners to unlock robust efficiency, quality, reproducibility, and sustainability advantages across pharmaceuticals, nutritional and therapeutic proteins, cellular agriculture, and more. To learn more, visit prolific-machines.com. Contact [email protected] to co-develop the future of biology.
$55M sweet spot round size
2020
$55M
from 2 investors over 1 rounds
Prolific Machines raised $55M on July 6, 2024
Investors: Ki Tua Fund and + 8 Other investors